Supportive of this, it has been demonstrated that METTL3 expression is higher in PCa cells compared with non-malignant prostate cells, and that functional depletion of METTL3 alters basal and androgen-regulated transcription [68,71] and inhibits PCa cell proliferation [64]. The gene discussed is METTL3; the disease is posterior cortical atrophy.